SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bleeker who wrote (317)9/19/1998 12:46:00 PM
From: Arcane Lore   of 857
 
"Biotech firm alleges 'illegal' short-selling of stock"

"Shares of a small Philadelphia biotechnology company fell sharply yesterday as the company alleged that market manipulators were trying to undermine its stock by deriding a drug it is testing to treat chronic fatigue syndrome."

"In a statement, Hemispherx BioPharma said "illegal shorting" of the stock -- in which option traders, in effect, place bets that a company's share price will fall and benefit when it does -- "was orchestrated in conjunction with a purposefully erroneous and misleading report" published Thursday in the Sept. 28 issue of Business Week. The Center City company said it had reported its allegations to the Securities and Exchange Commission and the American and Nasdaq Stock Exchanges."

The full article by Jeff Gelles, Philadelphia Inquirer staff writer is at:
phillynews.com:80/inquirer/98/Sep/19/business/HEMI19.htm
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext